PPARGC1A and chronic kidney disease: In our experiments, we identified that activation of renal metabolism in the proximal tubule via the NAD+/PGC-1α/PPARα/FAO axis is an important mechanism contributing to the nephroprotective effects of NAD+ supplementation in CKD.